BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3939122)

  • 1. Behaviour of cefmenoxime towards beta-lactamases.
    Labia R; Morand A; Ben Yaghlane H; Bryskier A
    Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of cefmenoxime for beta-lactamases: an analysis.
    Labia R; Morand A; Verchere-Beaur C; Bryskier A
    Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of ceftriaxone with beta-lactamases including those which hydrolyze cefotaxime].
    Labia R; Morand A; Kazmierczak A
    Pathol Biol (Paris); 1986 Oct; 34(8):908-12. PubMed ID: 3537935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cefdinir with beta-lactamases.
    Labia R; Morand A
    Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme kinetic studies with beta-lactamases against cefotaxime and other cephalosporins.
    Yan SY; Li JT
    Chin Med J (Engl); 1987 Dec; 100(12):940-4. PubMed ID: 3133166
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of cephalosporinase of enterobacteria by ceftriaxone].
    Péchinot A; Duez JM; Nordmann P; Kazmierczak A; Labia R
    Pathol Biol (Paris); 1986 May; 34(5):399-403. PubMed ID: 3534712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of ceftazidime towards beta-lactamases.
    Labia R; Beguin-Billecoq R; Guionie M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of beta-lactamases: in vitro phenomena and clinical relevance.
    Wiedemann B; Peter K
    J Int Med Res; 1990; 18 Suppl 4():58D-66D. PubMed ID: 2282970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moxalactam: an inactivator of beta-lactamases].
    Labia R
    Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime].
    Pechinot A; Duez JM; Bryskier A; Labia R; Kazmierczak A
    Pathol Biol (Paris); 1984 May; 32(5):386-8. PubMed ID: 6330649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.